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I. Executive Summary 
  
Localized tumor hyperthermia therapy is a treatment that involves heating cancerous tissue to 
temperatures that result in tumor cell necrosis, while preventing damage to surrounding healthy 
tissue. Hyperthermia therapy treatments reported in the literature have shown that nanoparticles 
can be injected into a targeted tumor, allowing specific regions to undergo treatment and 
reducing the healthy tissue that is affected as well. Previous studies have shown that when the 
nanoparticles absorb specific wavelengths of radiation, they undergo resonance and emit heat. 
Thus, the targeted tumor can be heated through the actions of both tissue absorption, and heat 
emitted by the excited nanoparticles. This additional heat due to nanoparticles within a tumor can 
facilitate tumor heating over a given time-frame so as to prevent damage to surrounding healthy 
tissue. Our project aimed to investigate the efficacy of utilizing injectable ferromagnetic 
nanoparticles (with the properties of γ-hematite nanoparticles) to facilitate microwave heating of 
cancerous tissue.  
 
The first stage of our project was modeling the precise delivery and dispersion of a volume of 
nanoparticles in a targeted cancerous tissue. To do this, we built a 1D radially symmetric 
computational model in COMSOL to represent a tumor, and we computed the diffusion profile 
of the nanoparticles in this domain over the time directly after injection. Next, we built a 2D 
axisymmetric computational domain in COMSOL to model the heat treatment. This model 
included heating of the tumor tissue with a microwave probe, and then coupled this heating with 
heating due to the nanoparticle concentration in the tissue. Computing the heat and energy 
profiles for this heating model allowed us to then determine the optimal time after injection to 
begin the heat treatment to maximize cancer cell death, but minimize damage to healthy tissue. 
The optimal time was determined as the time when all cancerous tissue temperature had been 
raised above 43 °C, while the maximum surrounding healthy tissue temperature was still below 
43 °C. In conjunction with finding the optimal heating interval, our goal was to also find the 
optimized injection nanoparticle concentration, nanoparticle diffusion time, and microwave 
radiation power level. 
 
Computed temperature profiles that took into account heating due to the presence of 
nanoparticles within the tumor computational domain showed only a slightly larger proportion of 
the tumor domain reaching temperatures in excess of 43 °C than could be achieved when heating 
is due to radiation absorption by the tissue alone. Our conclusion is that, within the model, the 
nanoparticles are indeed absorbing microwave radiation, but they are not subsequently emitting 
as much heat as was expected. As they are absorbing radiation, they are blocking the passage of 
energy into the tissue areas directly surrounding the nanoparticles. Without the nanoparticles in 
the tumor domain, the microwave radiation can be absorbed entirely by the tissue, resulting in 
more desirable temperature profiles. Thus, our model as implemented does not demonstrate that 
injecting γ-hematite nanoparticles into a tumor facilitates probe-mediated microwave heating of 
said tumor. However, several changes could be made to our model to achieve more desirable 
results. For example, if the nanoparticles were injected so as to enclose the tumor targeted for 
destruction, then they would effectively create a barrier for microwave radiation to pass through, 
thus restricting the radiation heating primarily to the enclosed tumor region. Alternatively, the 
ferromagnetic nanoparticles could be magnetically tuned (using a varying magnetic field) during 
microwave radiation so that they do actually undergo resonance significantly, resulting in greater 
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heat emission and desirable temperature profiles. Regardless, we did successfully model probe-
mediated microwave radiation of a tumor for hyperthermia treatment using a complete 
electromagnetism module in COMSOL, something that has never been done before in this course. 
We found the optimum microwave probe power level and radiation time required to maximize 
tumor death while minimizing healthy tissue damage in our model. It follows that localized 
tumor hyperthermia therapy that uses a microwave-emitting probe for tumor destruction can be 
modeled and fine-tuned using COMSOL. With appropriate model modifications, it could be 
shown that ferromagnetic nanoparticles can be used to direct the microwave heating in the 
targeted region. Mass transfer and heat transfer models similar to the ones used in this project 
can be built with specific tumor geometries, tissue properties, and probe properties, and such 
models can be used to plan clinical applications of using probe-mediated microwave heating of 
cancerous tissue.  
II. Introduction   
Cancer is a generic term that refers to a broad collection of diseases characterized by 
uncontrolled and unregulated growth of mutated cells. There are over 200 different known 
cancers that afflict humans [14]. Unlike many diseases, cancer afflicts all demographics, 
regardless of economic status or other socially derived factors. Taking into account all the forms 
of this disease, cancer was the cause of 13% of all deaths worldwide in 2008, corresponding to 
approximately 7.6 million deaths worldwide [14].  
 
Over the last 30 years, cancer treatment has improved markedly. An important measure of the 
efficacy of cancer treatment is the 5-year relative survival rate. This is the percentage of patients 
with cancer that are alive five years after their diagnosis divided by the percentage of the general 
population of corresponding sex and age that are alive after five years. The 5-year relative 
survival rate in the U.S. has increased from 49% in 1977 to 68% in 2008 [1]. However, despite 
advances in treatment, the global prevalence of cancer continues to increase largely due to longer 
average life expectancy and increased risk factors in certain areas, such as limited access to 
cancer-reducing vaccinations and early-detection examinations [5]. Given current projections, in 
2030 it is estimated that 13-17 million people will die from cancer worldwide [14].  
 
The most common treatments of cancer are surgical tumor removal, radiation therapy, and 
chemotherapy [1]. Although relatively effective, these treatments are far from ideal. Surgical 
tumor removal is extremely invasive, while chemo and radiation therapies can present serious 
side effects. Thus, there is an increasing demand for treatments that are effective, but minimize 
invasiveness and undesirable side effects. Often the treatments that meet these requirements 
involve mechanisms for specifically targeting cancer cells while rendering healthy tissue 
unaffected. For example, antibodies specific to cancer cell surfaces can be used to deliver drugs 
or radiation directly to tumors, and new drugs are continually being developed that are better at 
distinguishing between malignant and normal cells [9]. One technique for specifically targeting 
tumors that has gained interest due to its economic feasibility and minimal potential for side 
effects is thermal therapy. 
 
Thermal therapy applies extreme cold, cryotherapy, or extreme heat, hyperthermia therapy, to the 
tumor with the objective of killing all the malignant tissue. We will explore thermal therapy in 
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this study, but we will only examine hyperthermia therapy because it has been shown that 
cancerous cells are particularly sensitive to high temperature compared to normal cells [12]. 
Hyperthermia therapy destroys tumors by heating them to temperatures greater than 43 °C. This 
temperature range has been shown to be effective at killing cancer cells [10]. For use in this 
study, we will utilize the concept cumulative equivalent minutes for T = 43°C, or CEM43°C, 
which standardizes the amount of hyperthermia treatment in terms of 43°C. 
 
One of the limitations of hyperthermia therapy is that when sufficiently heating tumor tissue for 
destruction it is inevitable that some surrounding healthy tissue will be destroyed. Thus, the 
success of hyperthermia therapy hinges on the ability to specifically target the area of interest. 
Several methods of localizing electromagnetic radiation, and its subsequent heating, to the tumor 
have been developed in the literature [4,6,10,12]. One method uses a microwave-emitting probe 
that can be inserted directly into the tumor [6]. Another proven method of localization involves 
injecting γ-hematite (Fe2O3) nanoparticles into the tumor, which can then be excited with 
microwaves [10]. In this study we will examine the effect of combining these two localization 
strategies. Although both of these strategies have been proven in isolation, the effect of 
combining them has not previously been studied.  
 
Specifically, the use of γ-hematite nanoparticles excited with a microwave frequency of 2.45 
GHz has been proven to be effective at raising tumor temperatures to the necessary critical levels 
for treatment [10]. Therefore, in this study we will model the use of a 2.45 GHz emitting probe 
inserted directly into the tumor in conjunction with injected γ-hematite nanoparticles. The 
nanoparticles will be assumed to be injected directly into the center of the tumor, after which 
they diffuse outward radially. Previous research has shown that both the distribution of 
nanoparticles and the duration of electromagnetic heating have large influences on the success of 
the treatment [12]. Thus, the goal of this study is to optimize nanoparticle diffusion time and 
duration of microwave heating. An optimized solution will achieve total tumor destruction, while 
minimizing healthy tissue damage. 
 
III. Design Objectives 
 
1. Develop a diffusion profile of the nanoparticles over time. 
2. Ensure total tumor destruction by reaching a lethal CEM43°C value 
3. Minimize damage to healthy tissue by keeping it below its lethal CEM43°C value 
4. Determine the optimal time after injection to begin microwave radiation. 
5. Determine the optimal duration of microwave radiation heating. 
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IV. Methods 
 
IV.a. Model Development   
Using the guiding design objectives previously stated, we were able to formulate this physical 
problem into one that can be interpreted by COMSOL. One of the first steps in developing this 
model was to define the computational domain over which the physics would be applied. This 
involved not only determining the dimensions of our model, but assessing what boundary 
conditions are appropriate. Given that our model incorporates physics for mass transfer, heat 
transfer, and Maxwell’s equations for electrodynamics, the computational domains are physically 
represented differently with their own boundary conditions. These various domains can be seen 
below.  
 
IV.b. Schematic  
 
 
FIGURE 1. Mass transfer (1D radially symmetric): This figure represents the temporal radial 
movement of nanoparticles after initial injection within the volume represented by r = 0.25cm. 
 
For mass transfer computations, the domain is assumed to be homogenous in terms of material 
properties, and the boundary condition used is a pseudo infinite approximation whereby 
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concentration far from the injection site is zero. Diffusion will follow a 1D radial symmetric 
governing equation given by equation 1. 
 DAB 1r ∂∂r �r ∂cA∂r � = ∂cA∂t  ...................................................................................................................... (1) 
 
DAB is the diffusion coefficient in m2/s, cA is concentration in mol/m3, r is radial position in 
meters, and t is time in seconds. The purpose of the particles is to help direct the exact heating 
area from the microwave probe, which involves the use of both heat transfer and Maxwell’s 
equations. 
 
In examining the physics associated with microwave heating, it is useful to visualize a slightly 
different physical domain as given in Figure 2. 
 
 
 
FIGURE 2. Heat transfer (2D axisymmetric): This figure represents the temporal heating front 
produced from the microwave probe (grey cylinder on left wall), moving outward from r = 0cm 
to the outer edge of the tumor given by r = 1cm. 
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Figure 2 yet again incorporates a pseudo infinite assumption; the temperature fluxes at locations 
distant from the probe are assumed to be zero. The heating will be modeled with a 2D 
axisymmetric equation as given by equation 2. 
 
ρCp ∂T∂t = k �1r ∂∂r �r ∂T∂r� + ∂∂z �∂T∂z�� + Q��� + Q��� ....................................................................... (2) 
 
Here ρ is liver density (kg/m3), Cp is specific heat (J/(kg*K)), k is thermal conductivity 
(W/(m*k)), r is radial position in meters, z is vertical position in meters, t is time in seconds, Qbio 
is the blood perfusion heat source term, and Qmic is the is the microwave heating heat source term, 
which is the component that couples equation 2 to the electrical heating modeled by Maxwell’s 
equations. The microwave heating in the tissue is modeled by equation 3. 
 
∇ × µr−1(∇ × E) − k02 �εr − jσωε0�E = 0 ............................................................................................. (3) 
 
Here µ� is the relative permeability (unitless), E is the electric field (V/m), �0 is the wave number of 
free space (rad/m), εr is the relative permittivity (unitless), j is a scalar multiplier in the formula 
for the complex eigenfrequency (rad/s2), σ is the electric conductivity (S/m), ω is the angular 
frequency (rad/s), and ε0 is the permittivity of free space (F/m). Additionally, the boundary 
conditions for the probe are designated as input power at the top of the dielectric, and then a 
scattering boundary condition is used on the on the three walls not containing the probe. A 
scattering boundary condition is where waves orthogonal to the wall escape the surrounding 
tissue, while waves at other angles are reflected back into the tissue. 
 
The specific geometry for this probe can be seen in Figure 3.  
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FIGURE 3. Probe schematic showing energy release through the air window between dielectric 
and catheter wall. 
 
While the material properties of liver tissue in the domain given by Figure 2 are assumed to be 
constant, the inclusion of nanoparticles is assumed to change the electrical properties depending 
on the local concentration. This was incorporated into our model by finding values for 
nanoparticle electrical properties in the literature on a per 25% volume fraction basis, and then 
extrapolating how lower fractions would influence the tissue. This is presented in more detail 
when discussing the parameters in Table 1, as seen in Appendix A.  
 
The values presented in Table 1 were accumulated through investigating existing literature on 
models that show similarity to ours. As previously mentioned, while some parameters (such as 
those associated with mass and heat transfer) remain constant, it is assumed that the electrical 
properties are altered by the presence of nanoparticles. Because particle permittivity and 
permeability are given on a volume fraction basis, this allows the incorporation of these 
parameters into those of the liver. Equation 4 represents how the permittivity in the liver can be 
adjusted to include the presence of particles. 
 
eps_liver*(1−v_c)+(v_c/0.25)*(eps_p25+i*eps_dp25) ................................................................ (4) 
 
Here, eps_liver, eps_p25, and eps_dp25 are defined in Table 1, i represents the imaginary portion 
of the relative permittivity, and v_c is the volume fraction as a function of particle concentration, 
given by particle concentration multiplied by particle volume and Avogadro’s number. This 
method seen in equation 4 can similarly be employed to compute for the corrected permeability 
and conductivity values. 
 
10  
With the previously mentioned parameters, the physics functions included in COMSOL are able 
to implement our governing equations and boundary conditions without much more numeric 
manipulation. The process of coupling the different physics starts by running the diffusion 
module, the final concentration profile of which is passed to the EM heating module for use in 
modifying the local electrical properties through the use of equation 4 and its counterparts for 
electrical permeability and conductivity. The next phase is to run the EM heating physics, where 
the microwave power input, P_in is applied for t_heat amount of time, and then the heat is 
allowed to dissipate over the period of t_cool. This microwave heating effectively acts as a 
source term for the bio-heat physics module, which translates the energy density profile created 
by the microwave input into heat generation within the tissue.  
 
V. Results and Discussion  
V.a. Optimization Goals 
 
One of the most critical components of developing a computational model is to optimize the 
parameters so as to predict the best conceivable results. In the case of our model, the initial goal 
was to optimize c_max, t_diff, P_in, and t_heat so as to maximize tumor ablation and minimize 
healthy tissue ablation. However, as will be discussed later, it has become apparent from our 
model that particles are not undergoing heat generation when exposed to the microwave field, 
and therefore heating results after diffusion has occurred vary minutely from the model when no 
particles are present. Therefore, the primary parameters we will be interested in optimizing are 
P_in and t_heat. 
 
The success of model optimization is judged through the use of an objective function. In our case, 
we are using cumulative equivalent minutes for T = 43°C, or CEM43°C. What this provides is a 
normalizing equation for our model that presents heating time at different temperatures in terms 
of the equivalent time that would be observed at 43°C for the same damage to occur. For 
example, a minute at 50°C is equivalent to 128 minutes at 43°C, so over this minute, the tissue 
experiences 128 minutes of CEM43°C. Equation 5 shows the CEM43°C function. 
 CEM43°=�� ∗�43−� ................................................................................................................. (5) 
 
In equation 5, ∆t is the time interval in minutes, and R is a constant equal to 0.5 when 
temperatures exceed 43°C or equal to 0.25 when temperatures are below 43°C [3]. T is the 
average temperature of the region of interest during the time interval t, and if T is not constant 
over time, CEM43°C must be integrated over the time interval of interest. 
 
When implementing this equation as part of our objective function, the goal will be to have the 
CEM43°C values for the tumor domain reach lethal levels while minimizing necrosis to healthy 
tissue, which will be quantified by the volume of tumor tissue that reaches lethal CEM43°C 
values minus the volume of healthy tissue that reaches lethal CEM43°C temperatures. 
Implementation of this function will be discussed in more detail later.  
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V.b. Preliminary Results 
 
Following the model outlined in the previous section, surface plots of radiation energy density 
and temperature were developed. Additionally, diffusion of the nanoparticles is modeled 
assuming the injection volume is 0.065 cm3, and then the profile is plotted after diffusion has 
progressed over 10 hours.    
 
FIGURE 4. Model diffusion profile after 10 hours have elapsed from initial injection. 
Concentration is in mol/m3.  
The surface plot presented in figure 4 is indicative of our initial iteration of calculating a 
diffusion profile. As mentioned previously, this profile ultimately has little effect on the electric 
and heating profiles generated by our model. 
 
While including the nanoparticle concentration in this model is one of the pivotal aspects behind 
this novel cancer treatment, it is important to assess precisely how the presence of these particles 
influences both energy dissipation in the tissue, and the overall heating profiles developed over 
time.    
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 a. b. 
FIGURE 5. a. Energy dissipation profile (W/m2) without nanoparticles b. Energy profile with nanoparticles considered.  
Figure 5 shows the energy dissipation in W/m2 generated from the probe during situations when 
there is tissue heating alone, and when the electrical characteristics of the tissue are coupled with 
those of the nanoparticles at varying concentrations. Consistent with this minute change in 
electric field, the temperature surface plots similarly demonstrate that nanoparticles do not 
significantly increase the heat generation over the domain.  
 
 a. b. 
FIGURE 6. a. Temperature profile (°C) without nanparticles considered b. temperature profile 
with nanoparticles considered 
 
Figure 6 shows the temperature profiles generated with the conditions of nanoparticles not 
present (a.) and when they are present (b.) The background surface plot represents the profile for 
all temperatures recorded, and the three contour lines designate 45, 50, and 60°C from right to 
left. Note that the maximum attained temperatures shift by barely 1.2°C between the plots with 
and without particles, and the contour lines barely shift, which further validates that the presence 
of diffuse nanoparticles has only a minimal effect on the end heating profile. However, the 
particles can still in fact guide heating by absorbing microwave energy, which will be explained 
in more detail shortly. 
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The results observed in figures 5 and 6 can be further elucidated by observing temperature 
profiles developed shortly after injection. 
 
 
 a. b. 
FIGURE 7: a. This shows a temperature profile plot (°C) when no nanoparticles are present in 
the model. The rainbow color scheme designates temperatures from 37 to 43°C, while the 
red/yellow scheme indicates areas of higher temperature. b. This surface plot includes the 
presence of particles in the initial injection site after no diffusion has been allowed to progress. 
 
From Figure 7, it is evident that rather than the nanoparticles acting as a heat source upon 
exposure to microwave radiation, they are in fact effectively blocking the passage of energy into 
this tissue area. Around the nanoparticle site, temperatures are much lower than when no 
particles are present, indicating that the particles are actually absorbing the microwave radiation 
and not emitting nearly as much heat as is released from tissue energy absorption. While this is 
not the result we anticipated, this energy absorption behavior could still be utilized in 
conjunction with microwave probe heating and varied injection sites in order to act as a barrier 
through which energy cannot pass, effectively creating a specified region for heating to occur. 
The reason why these effects are not observed after diffusion has been allowed to progress for 
many hours is that the particle density is sparse enough that tissue electric properties are 
predominantly considered, resulting in energy and heating profiles that appear the same as 
though no particles had been injected at all. 
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V.c. Optimized Results 
 
In order to implement the CEM43°C as our objective function, it is necessary to find values that 
are representative of lethal CEM43°C exposure times. Values such as these are obtained 
experimentally, and from a literature search are taken to be CEM43°C = 340 min for healthy 
liver tissue [3], and CEM43°C = 10 min for tumor tissue [2]. These values are represented by 
t43c_tiss and t43c_tum for liver and tumor tissue respectively, and are in units of seconds.  
 
For implementation into COMSOL, we utilized the built in diffusion module and defined 
equation 5 as a reaction source term. The solver would then effectively treat 1 mol/m3 as 
equivalent to 1 s CEM43°C, removing the need to implement this function through a differential 
equation. We created 2 diffusion modules, one for the tumor domain, and one for the healthy 
tissue, which was found to yield more reliable results than combining the two, due to the lethal 
CEM43°C thresholds being of different orders of magnitude. To further maintain numerical 
accuracy, the reaction (at a given location) was halted after lethal CEM43°C was reached, using 
a Boolean operator, (otherwise, the CEM43° can climb extraordinarily high and reduce accuracy 
along the boundaries of tissue that only just reach the threshold). R is also found by using a 
Boolean operator dependent on the current temperature, as given by equation 6, below. 
 
R = (T>=(43[degC]))*0.5+(T<(43[degC]))*0.25 ......................................................................... (6) 
 
 
CEM43°C was normalized over each region (tumor and healthy tissue) using the following 
functions, so as to incorporate partial damage while ignoring damage beyond the lethality 
threshold: 
 
t43n_tumor = min(t43_tum,t43c_tum)/t43c_tum ......................................................................... (7) 
t43n_tissue = min(t43_tiss,t43c_tiss)/t43c_tiss ............................................................................ (8) 
 
This brings the CEM43°C evaluation for each region to within the range of zero to one for a unit 
volume. These functions were then integrated over the volume of the tumor and volume of the 
healthy tissue to obtain obj_tum and obj_tiss, the two components of the objective function: 
 
obj = obj_tum – obj_tiss ............................................................................................................... (9) 
 
This objective can be conceptualized as the difference in the volume-weighted damage to the 
tumor and the tissue—thus if equal volumes of tissue and tumor die, the objective is zero. To 
increase readability, the objective function was normalized once again to the best possible 
outcome: all of the tumor dead, and no damage to healthy tissue. In Table 2 (below), we see the 
objective in each case as a percentage of the objective of this perfect outcome. 
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Table 2. Optimized results from the parametric sweep against heating time and input power. The 
green regions represent the highest rates of success for the objective function with the highest 
equating to a 95.5% success from P_in = 10W and t_heat = 420s. 
  
P_in [W] 
  
5 10 15 20 25 30 35 40 45 50 
t_heat 
[s] 
60       48.2% 64.8% 78.2% 86.3%       
120   35.5%   92.1% 85.7% 71.9%   31.3%   -24.3% 
180     94.2% 83.5% 62.0%           
240   72.9% 90.7% 69.3%   -17.4%   -134.4%   -229.8% 
300   87.6% 84.5%               
360 28.0% 94.1% 78.0% 36.1%   -108.8%   -238.4%   -366.7% 
420 33.1% 95.5%                 
480 37.4% 94.0%   3.6%   -169.6%   -316.8%   -460.8% 
540 41.0%                   
600 44.5% 91.0%   -25.2%   -209.7%   -380.5%   -530.7% 
 
From the results in Table 2, it is apparent that there are a range of values that enable high success 
rates from our objective function. Notably, the most successful results are obtained with a power 
input of 10 W for 420 s of heating. In this case, all of the tumor dies, so the 4.5% error is caused 
by healthy tissue damage. These results are strictly from probe heating with no contribution from 
the particles, but the previously displayed results indicate that high concentrations of particles 
can may be useful for effectively containing the energy profile, thus reducing ambient heating. 
 
Using the results from Table 2, the objective function can be plotted as seen below in Figure 8, 
below. 
 
FIGURE 8. This shows the objective function obtained from utilizing the optimized results of 
P_in = 10W and t_heat = 420s, and the data is presented as a percentage of tumor and healthy 
tissue that reaches their critical temperature over time. The green line at the top represents the 
ideal situation where all tumor tissue dies and no healthy tissue is harmed, and the objective line 
in blue is the difference between the tumor and tissue curves.  
From Figure 8, given that the results for a 95.5% success rate are utilized, it makes sense that the 
true objective function, as seen in blue, plateaus out very close to the optimum possible results. 
As seen in Table 2, there are a number of power inputs and heating time combinations that can 
provide high success rates given our objective function, and while certain characteristics of the 
objective plot may change with these altered parameters, the main characteristic of success is 
plateauing of the objective function close to the perfect condition line.  
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V.d. Accuracy Check 
 
In order to help verify the validity of our model, our computed results can be compared against 
existing experimental research.  
 
FIGURE 9. Probe experimental heating effects: (Wongtrairat, 2011)13 These curves represent 
temperatures in porcine liver tissue with depth along the side of a microwave heating probe that 
is activated for 60s at either 50, 100, or 150W. The observation line runs 5mm away and parallel 
to the microwave probe. Microwave frequency is also 2.45 GHz here. 
 
 
a.       b.  
FIGURE 10. Probe accuracy check: a. Computed plot of cut line 5 mm from probe after 60s of 
heating at varying power inputs. b. (Lubner, 2010)4 the blue line is a plot of microwave heating 
of porcine tissue with a power input of 50W. 
 
From our computed accuracy check seen in figure 10 a to verify that strictly probe-heating 
results are consistent with findings in the literature, we can see that the maximum computed 
temperature values from our model exceed the results seen in Figure 9 by up to 38%. However, 
the general trend observed between lines of varying energy input are consistent between 
experimental and computed results, indicating that our model reacts to changes in input energy in 
a way that is consistent with the experimental results. From comparing our analytical results to 
the experimentally collected ones, the higher temperatures observed in our model could 
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potentially be accounted for by the exclusion of parameters to take water vaporization into 
account. The drop off in slope of Figure 10 b at 100°C results from boiling point being reached, 
In our actual model, we do not reach temperatures exceeding 100°C, so have not included 
parameters to account for the latent heat of vaporization, which would diminish the temperature 
of our model values though energy absorption to drive phase change. 
 
Another important accuracy check to consider is the specific heating effects of the excited 
nanoparticles.  
 
FIGURE 11. Particle experimental heating effects (Sakran, 2004)5 These data show the 
change in surface temperature of 30-250 nm diameter magnetite nanoparticles heated with 
microwave frequencies of 9.2 GHz and power input of 0.5 W. The legend on the upper right 
designates changes in magnetic field that yield small variances in particle surface temperature. 
The rapid initial increase in temperature is due to microwave heating of the ambient acrylic, 
while the subsequent magnetic tuning results in variations of 2-3°C caused by particle resonance. 
 
To compare to our model, we will utilize these same parameters for probe heating with 
nanoparticles being considered.     
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  a. b. 
FIGURE 12. a. Particle accuracy check: Heating conducted with power = 0.5 W and 
frequency = 9.2 GHz for 900 s. b. Accuracy check average temperature over tumor domain. 
 
Figure 12 shows the heat profile attained after 900 s of heating with particles considered, power 
input = 0.5 W, and frequency = 9.2 GHz. While the maximum change in temperature seen in 
Figure 12 a is only about 4.7°C as compared to the approximately 12°C change seen in the 
experimental results in Figure 11, an important note to consider is that the experimental results 
only consider the change in temperature of the particles and surrounding acrylic, whereas our 
model incorporates thermal properties of the liver tissue on a much larger domain. Therefore, it 
is reasonable to observe that there is less temperature change in our model, which could 
potentially be accounted for by replacing tissue electrical and thermal properties with those of 
the acrylic. Additionally, as previously discussed, given that our model indicates that 
nanoparticles are absorbing energy but not necessarily emitting much heat, it is reasonable to 
assume that the behavior observed in Figure 12 is strictly from microwave heating of the tissue.  
 
As a continuation to the experimental results seen in Figure 11, Sakran proposed that the increase 
in temperature of magnetite nanoparticles embedded in acrylic could be modeled by equation 7.  
∆� =  �
4���
 .............................................................................................................................. (10)  
Where P is the power absorbed by the particles, k is the thermal conductivity of the surrounding 
media, and r is the radius of the nanoparticles. As compared to the results of Sakran where a 2-
3°C change was expected from nanoparticle heating, it would be beneficial to include a varying 
magnetic field in our model to see if the steady state temperature of Figure 12 b is perturbed.    
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V.e. Sensitivity Analysis 
 
In order to ascertain how sensitive our model is to changes in some of our assigned parameters, 
we conduct a sensitivity analysis that computes the solutions over a range of defined parameters.  
 
   
FIGURE 13. Varying diffusion coefficient (diff_coef) sensitivity analysis. 
 
Figure 13 shows the changes in concentration values with time at a point 0.005 m from the center 
of the tumor while changing the particle diffusion coefficient with a constant initial 
concentration of 1.661*10-6 mol/m3. The values inputted for diffusion coefficient are +/- 10 % of 
our model value of 9*10-11 m2/s. From this figure, we can see that while the curves are dependent 
to some extent on diffusion coefficient, the final concentration values after 10 hours of diffusion 
vary by less than 1.67% from the unperturbed value. This indicates that our model is not highly 
sensitive to diffusion coefficient values. In order to develop further certainty in these values, 
physical experimentation would need to be conducted for the particular sized particles of interest 
within both liver and tumor tissue. 
 
For thermal and electromagnetic properties, we used coefficients for our input parameters (for a 
parameter denoted “eps_dp25”, the coefficient was labeled “eps_dp25_coeff”). Variations were 
introduced by performing a parametric sweep over coefficient values of 0.9 and 1.1 (10% 
changes), with a comparison to coefficients of 1 (the unperturbed parameters). 
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FIGURE 14. Thermal and electrical property sensitivity analysis: The red bars are indicative of 
a +10% modification to our model parameter (shown on left axis), and the blue bars represent a -
10% change. The length of the bars indicates variation from the model computed temperature of 
52.82°C. 
 
From Figure 14, it is apparent that most of these parameters do not heavily influence the results 
obtained in our model. The largest change presented by the frequency parameter, f, resulted in a -
3.7°C change in model temperature, which is significant given that this equates to approximately 
a 7% change from the model. However, our model frequency of 2.45 GHz is a commonly 
recognized ISM band for use in microwave heating. The next largest variation is caused by the 
relative permittivity of the catheter (eps_cat), which is a measure of the material’s ability to store 
electromagnetic radiation. Given that our model value for eps_cat was taken from previous 
experimental work with a similar microwave probe, this value is taken as considerably reliable. 
Finally, changes in power input (P_in) does illicit a notable temperature change in the model, but 
given that this is a parameter that will be used for system optimization, it is reassuring to see that 
changing it does result in alterations of the final results. The remaining parameters illicit no more 
than a 2% change in computed temperature values, indicating that the system is not heavily 
sensitive to their change.    
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VI. Conclusion and Design Recommendations 
 
We varied the nanoparticle injection concentration, and time after injection to determine what 
combination of these parameters gave a nanoparticle concentration in the tumor that allowed us 
to use a realistic microwave power for achieving tumor destruction while damaging as little 
healthy tissue as possible. An objective function was used to determine the optimal duration of 
microwave radiation heating. We assumed the tumor region needed to be above 43 °C for 
destruction, and that the healthy tissue needed to stay below 43°C to prevent destruction. Our 
objective function reflected this and was computed as a function of heating time to determine the 
optimal heating time.  
 
Through the development of this computational model, it is apparent that our overall system has 
the potential for use in targeted tumor heating that minimizes the damage to surrounding healthy 
tissue. For the specific situation modeled, the optimal parameters were found to be an input 
power of 10W over a period of 420s, allowing for a 95.5% success rate of killing tumor tissue 
while preserving healthy liver. While these are optimized for one particular situation, the 
inclusion of different tumor geometries and thermal and electric parameters can easily be 
modified so as to optimize the treatment of different situations.  
 
Based on our computed results where the nanoparticles do not emit heat as we expected but 
effectively diminish the electric field, for future expansion of this model, it would be beneficial 
to experiment with varying the injection site so as to create a boundary in which heating would 
be contained. This would still allow probe mediated hyperthermia treatment to be utilized, but to 
a more controlled extent by protecting the surrounding tissue. Additionally, a continuation of our 
current model could be developed by including different magnetic field densities around the 
heating site. As seen from figure 11, this allows a certain degree of tuning to take place so that 
the particles begin to emit heat when subjected to a microwave field. 
 
Another possible modification to our model could be to experiment with different radiation 
frequencies. Our model value of 2.45 GHz is a common ISM band frequency, but 
experimentation with other microwave frequencies could potentially yield improved results. 
Additionally, it would be good to investigate the use of radiofrequency radiation coupled with 
nanoparticle hysteresis heating. Radiofrequencies are able to penetrate many centimeters into the 
tissue, possible removing the need to utilize a probe. While the probe is minimally invasive 
given its small diameter, it still provides a possible infection site and necessitates more technical 
training in applying the therapy.  
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VII. Appendix A: Mathematical Statement of the Problem 
 
The governing equations and boundary conditions are succinctly condensed below. 
Governing equations:  
Mass Transfer: DAB 1r ∂∂r �r ∂cA∂r � = ∂cA∂t   
 
 
Bio-heat Transfer: 
ρCp ∂T∂t = k �1r ∂∂r �r ∂T∂r� + ∂∂z �∂T∂z�� + Q��� + Q��� 
 
Microwave heating: Maxwell’s equations are used here in a 2D axisymmetric domain. 
∇ × µr−1(∇ × E) − k02 �εr − jσωε0�E = 0  
Boundary and Initial conditions:  
Mass Transfer: 
Boundary conditions: 
∂c
∂r
|r=0 = 0, and c|r=rmax = 0, where rmax is sufficient for pseudoinfinite conditions. 
Initial conditions: c|t=0; r≤rinjection = co, c|t=0; r>rinjection = 0 
 
Heat Transfer: 
Boundary conditions: 
∂T
∂r
|r=0 = 0 and ∂T∂r |r=rmax = 0, where rmax is sufficient for pseudoinfinite conditions. 
∂T
∂z
|z=0 = ∂T∂z |z=zmax = 0, where zmax is sufficient for pseudoinfinite conditions. 
Initial conditions: T|t=0 = 37°C, where t = 0 is the start of radiation, after the diffusion period. 
 
Microwave energy input:  
A power input, P, is defined at the top boundary of the dielectric of the probe, and scattering 
boundary conditions are applied to the three walls that do not contain the probe. 
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Table 1. Parameters and Constants used in the development of the model. 
 
Parameters/Constants COMSOL 
Name 
Value Source 
Blood Density rho_blood 1000.0 kg/m3 13 
Blood Specific Heat Cp_blood 3639.0 
J/(kg·K) 
13 
Blood Perfusion Rate omega_blood 0.0036000 1/s 13 
Blood Temperature T_blood 310.15 K 13 
Liver Relative Permittivity eps_liver 43.030 13 
Liver Electric Conductivity sigma_liver 1.6900 S/m  13 
Liver Thermal Conductivity k_liver 0.56000 
W/(m·K) 
13 
Dielectric Relative Permittivity eps_diel 2.0300 13 
Catheter Relative Permittivity eps_cat 2.6000 13 
Microwave Frequency f 2.4500E9 Hz 10 
Input Microwave Power P_in 20.000 W 13 
Nanoparticle in Tumor Diffusion Coefficient D 9E-11 m2/s 7 
Nanoparticle Volume V_particle 6.5450E-23 m3 10 
Default maximum element size e_max 0.0067000 NA 
Initial Nanoparticle Concentration in Injection 
Domain 
c0,1 1.661E-6 
mol/m3 
10 
Initial Nanoparticle Concentration Everywhere 
Else 
c0,2 0 mol/m3 NA 
Initial Temperature Everywhere T0 310.15 K NA 
Real permittivity of nanoparticles at 25% 
volume fraction 
eps_p25 5.5  10 
Imaginary permittivity of nanoparticles at 25% 
volume fraction 
eps_dp25 0.7 10 
Real permeability of nanoparticles at 25% 
volume fraction 
mu_p25 1.5 10 
Imaginary permeability of nanoparticles at 25% 
volume fraction 
mu_dp25 0.7 10 
Permittivity of free space eps_o 8.85E-12 F/m SOURCE? 
Time for diffusion t_diff 10 hrs = 
36000s 
NA 
Time for powered heating t_heat 300 NA 
Cooling time after t_heat followed by model t_cool 300 NA 
Volume of individual particles V_particles 6.545*10-23 m3 NA 
Lethal CEM43°C for tumor t43_tum 600 s 2 
Lethal CEM43°C for liver tissue t43_tiss 20400 s 3 
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VIII. Appendix B: Mesh Convergence 
 
 
FIGURE 15. Mesh convergence analysis.  
 
Figure 15 shows a mesh convergence analysis at a point at the interface between tissue and probe. 
We can see that with increasing refinement, i.e. the inclusion of more elements, the temperature 
profile converges on the plateaued region seen after 3000 elements are used. This indicates that 
using mesh densities higher than approximately 3000 triangular elements is appropriate for 
eliminating discretization error caused by meshing.  
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